Industrially useful polyploid yeasts such as the brewing yeasts do not possess any auxotrophic genetic markers and hence are not easily amenable to plasmid-mediated DNA transformations. In an attempt to obtain genetic markers, a number of useful Saccharomyces sp. strains and some amylolytic Schwanniomyces sp. strains were tested for their susceptibility to the antibiotic Geneticin G418, a 2-deoxystreptamine reported to be active against bacteria, yeasts, and plant and animal cells. All of the Saccharomyces sp. strains, including the brewing strains, were found to be susceptible to G418 in the concentration range of 150 to 500 ,ug/ml. Of the three Schwanniomyces species investigated, only Schwanniomyces castellii (strain 1402) was found to be resistant to G418 at concentrations up to 1 mg/ml. Resistance was exhibited both in liquid media and on glycerol-peptone-yeast extract agar plates. This finding is interesting in view of the possibility of using this strain as a DNA donor for transformations aimed at introducing the amylolytic capability into brewing yeasts.
In recent years there has developed a great deal of interest in the genetic manipulation of industrial yeast strains. The purpose of improving these already proven microbes has been to broaden their substrate-utifizing capability or to use them for producing foreign proteins of interest, such as insulin and interferon. Industrial yeast strains such as the brewing yeasts are polyploid/aneuploid and are genetically very stable (7) . As a result of this, it is very difficult to obtain auxotrophic markers in such strains; consequently, plasmidmediated transformation presents problems. The amylolytic yeast genus Schwanniomyces has not been genetically characterized. However, members of this genus have been found to produce extracellular a-amylase and glucoamylase with debranching activity (6) . They are, thus, potential donors of genetic material for transforming a brewing strain of Saccharomyces sp. to enable it to utilize starch and dextrins which form a significant part of the nonfermented carbohydrates remaining in the final beer. Introduction of the genes for aamylase and glucoamylase into a stable brewing yeast would also be of great value for producing industrial fermentation ethanol from starch substrates.
With a view to developing such a transformation system, strains of Saccharomyces spp. and Schwanniomyces spp.
were tested for their susceptibility to various antibiotics, including gentamycin, lincomycin, and neomycin, and the response to the aminoglycoside 2-deoxystreptamine Geneticin G418 (2) was found to be most interesting. The antibiotic G418 has been found to have a wide spectrum of activity against bacteria, yeasts, fungi, algae, and plant and animal cells (2, 4, 9, 10). In eucaryotic cells G418 interferes with the function of 80S ribosomes and blocks protein synthesis. Davies and Jimenez (2) (wt/vol) glucose, adjusted pH 5.0. Cells were pregrown in PYN medium and transferred to a fresh 200 ml of PYN medium in 500-ml shake flasks with or without an appropriate concentration of filter-sterilized G418. The flasks were agitated in a rotary shaker at 30°C. One-to 3-ml samples were periodically taken, and the optical density at 600 nm (OD600) was immediately deteritiined. For determining cell viability, an aliquot of the sample was mixed with a 0.01% solution of methylene blue and viable cells (no dye uptake) were counted, using a hemacytometer placed under a microscope as described previously (1) .
Saccharomyces cerevisiae 1434 (RH218) has been used extensively for transformations involving complementation of the TRPJ gene (5). When examined for resistance to G418, the yeast strain was found to be very susceptible at G418 concentrations of 150 to 500 ,ug/ml. Similarly (Fig. 1) 
